The invention relates to a composition including at least one neutralising agent, preferably selected among antacids, H2-receptor antagonists, and proton-pump inhibitors, to be used by ingestion by a patient, for preventing or treating the isolated, frequent or recurring appearance of at least one aphtha in said patient.